Hormone therapy following the Women's Health Initiative (WHI) Study: Perception of gynecologists in Brazil

Minerva Ginecologica

Volumn 57, Issue 5, 2005, Pages 563-568

  Bonassi Machado, R ^a,e   Fernandes, C E ^b   Maia, E ^a   De Melo, N R ^c   Chada Baracat, E ^d  

^a Faculdade de Medicina   (Brazil)

^b FACULDADE DE MEDICINA DO ABC   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e FACULDADE DE MEDICINA DE JUNDIAÍ   (Brazil)

Author keywords

Hormone replacement therapy; Menopause; Postmenopause; Questionnaires; Women's health initiative

Indexed keywords

ESTROGEN; GESTAGEN;

ARTICLE; BRAZIL; ESTROGEN THERAPY; GYNECOLOGY; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; PHYSICIAN; POSTMENOPAUSE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE;

BRAZIL; FEMALE; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HORMONE REPLACEMENT THERAPY; HUMANS; QUESTIONNAIRES; WOMEN'S HEALTH;

EID: 27844489486     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. MacLennan A, Lester S, Moore V. Oral oestrogen replacement therapy versus placebo for hot flushes (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software; 2003.
2. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942-4.
3. Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 2001;285:2891-7.
4. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 1998;92(4 Pt 2):722-7.
5. Hulley S, Grady D, Furberg C, Furberg C, Herrington D, Riggs B et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-12.
6. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
7. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004;291:47-53.
8. Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol 2003;102:1225-32.
9. Blumel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gomez MS et al. Patients' and clinicians' attitudes after the Women's Health Initiative study. Menopause 2004;11:57-61.
10. McDonough PG. The randomized world is not without its imperfections: reflections on the Women's Health Initiative Study. Fertil Steril 2002;78:951-6.
11. Speroff L. HT. a clinician demurs. Fertil Steril 2003;80 Suppl 4:15-8.
12. Schneider HP. The view of The International Menopause Society on the Women's Health Initiative. Climacteric 2002;5:211-6.
13. Skouby S. Consequenses for HRT following the HERS II and WHI reports: the primum non nocere is important, but translation into quo vadis is even more essential. Acta Obstet Gynecol Scand 2002;81:793-8.
14. Barlow DH. Time to reflect on the Women's Health Initiative (WHI) study. Hum Reprod 2003;18:1-3.
15. Notelovitz M. The clinical practice impact of the Women's Health Initiative: political vs biologic correctness. Maturitas 2003;44:3-9.
16. Ena G, Rozenberg S. Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study. Hum Reprod 2003;18:2245-8.